AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-85
Results: 51-75/85
LEUKOCYTOSIS AND INCREASED MORTALITY FOLLOWING ACUTE MYOCARDIAL-INFARCTION - A COMMUNITY-WIDE PERSPECTIVE
Authors: FURMAN MI BECKER RC YARZBESKI J SAVAGEAU J GORE JM GOLDBERG RJ
Citation: Mi. Furman et al., LEUKOCYTOSIS AND INCREASED MORTALITY FOLLOWING ACUTE MYOCARDIAL-INFARCTION - A COMMUNITY-WIDE PERSPECTIVE, Circulation, 92(8), 1995, pp. 3188-3188
CARDIOVASCULAR-DISEASE IN WOMEN - FOREWORD
Authors: BECKER RC ALPERT JS
Citation: Rc. Becker et Js. Alpert, CARDIOVASCULAR-DISEASE IN WOMEN - FOREWORD, Cardiology, 86(4), 1995, pp. 263-263
CARDIOVASCULAR-DISEASE IN WOMEN - FACTS AND STATISTICS
Authors: BECKER RC
Citation: Rc. Becker, CARDIOVASCULAR-DISEASE IN WOMEN - FACTS AND STATISTICS, Cardiology, 86(4), 1995, pp. 264-264
EDUCATION AND CLINICAL RESEARCH ISSUES IN WOMENS HEALTH
Authors: BECKER RC
Citation: Rc. Becker, EDUCATION AND CLINICAL RESEARCH ISSUES IN WOMENS HEALTH, Cardiology, 86(4), 1995, pp. 270-271
PRIMARY PREVENTION OF CORONARY HEART-DISEASE IN WOMEN
Authors: MEILAHN EN BECKER RC CORRAO JM
Citation: En. Meilahn et al., PRIMARY PREVENTION OF CORONARY HEART-DISEASE IN WOMEN, Cardiology, 86(4), 1995, pp. 286-298
CORONARY THROMBOLYSIS IN THE TREATMENT OF WOMEN WITH ACUTE MYOCARDIAL-INFARCTION
Authors: BECKER RC
Citation: Rc. Becker, CORONARY THROMBOLYSIS IN THE TREATMENT OF WOMEN WITH ACUTE MYOCARDIAL-INFARCTION, Cardiology, 86(4), 1995, pp. 299-303
EXPLORING THE MEDICAL NEED FOR ALTERNATE SITE TESTING - A CLINICIAN PERSPECTIVE
Authors: BECKER RC
Citation: Rc. Becker, EXPLORING THE MEDICAL NEED FOR ALTERNATE SITE TESTING - A CLINICIAN PERSPECTIVE, Archives of pathology and laboratory medicine, 119(10), 1995, pp. 894-897
ANTITHROMBOTIC THERAPY - AN ABBREVIATED REFERENCE FOR CLINICIAN
Authors: BECKER RC ANSELL J
Citation: Rc. Becker et J. Ansell, ANTITHROMBOTIC THERAPY - AN ABBREVIATED REFERENCE FOR CLINICIAN, Archives of internal medicine, 155(2), 1995, pp. 149-161
TOWARD ACHIEVING OPTIMAL REPERFUSION - REVISITING THROMBOLYSIS
Authors: BECKER RC
Citation: Rc. Becker, TOWARD ACHIEVING OPTIMAL REPERFUSION - REVISITING THROMBOLYSIS, Coronary artery disease, 5(8), 1994, pp. 717-722
THE CLINICAL USE OF FLOW-CYTOMETRY FOR ASSESSING PLATELET ACTIVATION IN ACUTE CORONARY SYNDROMES
Authors: BECKER RC TRACY RP BOVILL EG MANN KG AULT K
Citation: Rc. Becker et al., THE CLINICAL USE OF FLOW-CYTOMETRY FOR ASSESSING PLATELET ACTIVATION IN ACUTE CORONARY SYNDROMES, Coronary artery disease, 5(4), 1994, pp. 339-345
A PILOT TRIAL OF RECOMBINANT DESULFATOHIRUDIN COMPARED WITH HEPARIN IN CONJUNCTION WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ASPIRIN FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI)-5 TRIAL
Authors: CANNON CP MCCABE CH HENRY TD SCHWEIGER MJ GIBSON RS MUELLER HS BECKER RC KLEIMAN NS HAUGLAND JM ANDERSON JL SHARAF BL EDWARDS SJ ROGERS WJ WILLIAMS DO BRAUNWALD E
Citation: Cp. Cannon et al., A PILOT TRIAL OF RECOMBINANT DESULFATOHIRUDIN COMPARED WITH HEPARIN IN CONJUNCTION WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ASPIRIN FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI)-5 TRIAL, Journal of the American College of Cardiology, 23(5), 1994, pp. 993-1003
HEMOSTATIC MARKERS PREDICT CLINICAL EVENTS IN PATIENTS TREATED WITH RT-PA AND ADJUNCTIVE ANTITHROMBOTIC THERAPY
Authors: SCHARFSTEIN JS GEORGE D BURCHENAL JEB CANNON CP BECKER RC EISENBERG PR ABENDSCHEIN DR SOBEL BE BRAUNWALD E LOSCALZO J
Citation: Js. Scharfstein et al., HEMOSTATIC MARKERS PREDICT CLINICAL EVENTS IN PATIENTS TREATED WITH RT-PA AND ADJUNCTIVE ANTITHROMBOTIC THERAPY, Journal of the American College of Cardiology, 1994, pp. 10000056-10000056
THE ASSOCIATION BETWEEN HEPARIN CONCENTRATION AND MEASURED ANTICOAGULANT EFFECT BY 4 COMMERCIALLY AVAILABLE ACT ASSAYS
Authors: WEINER BH BECKER RC TRACY RP BOVILL EG CORNELL E BALL SP
Citation: Bh. Weiner et al., THE ASSOCIATION BETWEEN HEPARIN CONCENTRATION AND MEASURED ANTICOAGULANT EFFECT BY 4 COMMERCIALLY AVAILABLE ACT ASSAYS, Journal of the American College of Cardiology, 1994, pp. 10000185-10000185
BETA-ADRENERGIC-BLOCKADE FOLLOWING THROMBOLYTIC THERAPY - IS IT HELPFUL OR HARMFUL
Authors: BECKER RC
Citation: Rc. Becker, BETA-ADRENERGIC-BLOCKADE FOLLOWING THROMBOLYTIC THERAPY - IS IT HELPFUL OR HARMFUL, Clinical cardiology, 17(4), 1994, pp. 171-174
THROMBOLYTIC RETREATMENT WITH TISSUE-PLASMINOGEN ACTIVATOR FOR THREATENED REINFARCTION AND THROMBOTIC CORONARY REOCCLUSION
Authors: BECKER RC
Citation: Rc. Becker, THROMBOLYTIC RETREATMENT WITH TISSUE-PLASMINOGEN ACTIVATOR FOR THREATENED REINFARCTION AND THROMBOTIC CORONARY REOCCLUSION, Clinical cardiology, 17(1), 1994, pp. 3-13
CARDIOGENIC-SHOCK COMPLICATING CORONARY-ARTERY DISEASE - DIAGNOSIS, TREATMENT, AND MANAGEMENT
Authors: GRELLA RD BECKER RC
Citation: Rd. Grella et Rc. Becker, CARDIOGENIC-SHOCK COMPLICATING CORONARY-ARTERY DISEASE - DIAGNOSIS, TREATMENT, AND MANAGEMENT, Current problems in cardiology, 19(12), 1994, pp. 697-742
PRIOR ASPIRIN USE IN UNSTABLE CORONARY-DISEASE - MYTH OF ASPIRIN RESISTANCE
Authors: BORZAK S KRAFT PL DOUTHAT L CANNON CP ANTMAN E MCCABE C MASSARO J ADELMAN B FUCHS J BECKER RC
Citation: S. Borzak et al., PRIOR ASPIRIN USE IN UNSTABLE CORONARY-DISEASE - MYTH OF ASPIRIN RESISTANCE, Circulation, 90(4), 1994, pp. 232-232
PRIOR ASPIRIN USE IN UNSTABLE CORONARY-DISEASE - MYTH OF ASPIRIN RESISTANCE
Authors: BORZAK S KRAFT PL DOUTHAT L CANNON CP ANTMAN E MCCABE C MASSARO J ADELMAN B FUCHS J BECKER RC
Citation: S. Borzak et al., PRIOR ASPIRIN USE IN UNSTABLE CORONARY-DISEASE - MYTH OF ASPIRIN RESISTANCE, Circulation, 90(4), 1994, pp. 232-232
BEDSIDE APTT MONITORING IS ASSOCIATED WITH LESS BLEEDING AMONG GUSTO PATIENTS RECEIVING IV HEPARIN FOLLOWING THROMBOLYTIC ADMINISTRATION
Authors: ZABEL KM GRANGER CB BECKER RC WOODLIEF LH CHESEBRO JH CALIFF RM
Citation: Km. Zabel et al., BEDSIDE APTT MONITORING IS ASSOCIATED WITH LESS BLEEDING AMONG GUSTO PATIENTS RECEIVING IV HEPARIN FOLLOWING THROMBOLYTIC ADMINISTRATION, Circulation, 90(4), 1994, pp. 553-553
BEDSIDE APTT MONITORING IS ASSOCIATED WITH LESS BLEEDING AMONG GUSTO PATIENTS RECEIVING IV HEPARIN FOLLOWING THROMBOLYTIC ADMINISTRATION
Authors: ZABEL KM GRANGER CB BECKER RC WOODLIEF LH CHESEBRO JH CALIFF RM
Citation: Km. Zabel et al., BEDSIDE APTT MONITORING IS ASSOCIATED WITH LESS BLEEDING AMONG GUSTO PATIENTS RECEIVING IV HEPARIN FOLLOWING THROMBOLYTIC ADMINISTRATION, Circulation, 90(4), 1994, pp. 553-553
USEFULNESS OF APTT TO PREDICT BLEEDING FOR HIRUDIN (AND HEPARIN)
Authors: CANNON CP BECKER RC LOSCALZO J GALLO P HENIS M EDWARDS SJ MCCABE CH BRAUNWALD E
Citation: Cp. Cannon et al., USEFULNESS OF APTT TO PREDICT BLEEDING FOR HIRUDIN (AND HEPARIN), Circulation, 90(4), 1994, pp. 563-563
USEFULNESS OF APTT TO PREDICT BLEEDING FOR HIRUDIN (AND HEPARIN)
Authors: CANNON CP BECKER RC LOSCALZO J GALLO P HENIS M EDWARDS SJ MCCABE CH BRAUNWALD E
Citation: Cp. Cannon et al., USEFULNESS OF APTT TO PREDICT BLEEDING FOR HIRUDIN (AND HEPARIN), Circulation, 90(4), 1994, pp. 563-563
EFFECTS OF TISSUE-PLASMINOGEN ACTIVATOR AND A COMPARISON OF EARLY INVASIVE AND CONSERVATIVE STRATEGIES IN UNSTABLE ANGINA AND NON-Q-WAVE MYOCARDIAL-INFARCTION - RESULTS OF THE TIMI IIIB TRIAL
Authors: BRAUNWALD E MCCABE CH CANNON CP MULLER JE KNATTERUD G THOMPSON B PRIOR MJ KUFERA J WILKINS P GIRO R RANDALL A FREDERICK M CANNER M DEPKIN J MONROE L BELL P DESVIGNENICKENS P LETENDRE C MANN KG BOVILL E COLLEN D TRACY RP CORNELL E COLLING CL PETERSON J CHAITMAN B SHAW L STOCKE K STONE PH RUTHERFORD JD MACCALLUM G WILLIAMS DO SHARAF BL MCKENDALL GR RILEY RS THOMAS ES FERREIRA P MIELE NJ ZARET BL WACKERS FJ JAIN D MCMAHON M THEROUX P DEGUISE P JUNEAU M SEGUIN MA NASMITH JB PALISAITIS D GAUDETTE G DIVER DJ BREALL J BERGER C BAIM DS DUNN S KIRSHENBAUM J CANNON C BATESRIORDAN D HERSON S DAUM R CAREY G MUELLER HS GOLDBERGER M GREENBERG MA MENEGUS MA VENTURA B HEMINGWAY K STEINGART R GAMBINO A COGLIANESE ME BILODEAU S ROBERTS R KLEIMAN NS HABIB G PULEO P TRAINOR K ROSE D DANGOISSE V COTE M DUMAIS B HARVEY R GERVAIS A PROULX G MIGNAULT JD ROULEAU JL PLANTE S OHARA G LEPAGE S DANGOISSE J LETOURNEAU C HOCHMAN J PEPE AJ WONG SC BROGUS D MCANULTY M THOMPSON CR WEBB JG PRIMEAU A BULLER C SAUNDERS L LEYA F MCKIERNAN T GRASSMAN E GALBRAITH E PICCHI R WILLERSON JT ANDERSON HV WEIGELT LA SANFORD CF MURPHY G SCHWIEGER MJ PORWAY MN JOELSON J PETERMAN M MARANTZ T WARWICK D GIBSON RS POWERS ER FAUBER NM SAYRE SL BELENKIE I WARNICA JW HALL C CHURCHILLSMITH T SHOOK TL MATTHEWS RV GRAY C MAHRER PR JORGENSEN MB NOCEDA J MAGORIEN R EATON G SHARPWILMER J BECKER RC GORE JM WEINER BH CORRAO JM COHEN LS REMETZ M MIRTO G ALEXANDER J GEGNY A HAMILTON W THORNTON T MAJOR M BIERMAN K STONNER T KRONENBERG MW CONTI VR DAVIS MJ FARRELL RW NUSYNOWITZ ML SCHMEDTJE JF ZWISCHENBERGER JB IBRAHIM A PALMERI ST MOREVRA AE HOSLER M CASAZZA L KELLS CM ONEILL BJ FOSTER CJ FAWCETT T NEDULCU V WILLIAMS M JACKSON M FELDMAN T SORRENTINO M PASTORET A MCCABE C BROWN BG CANNON CD COHEN LE RAPAPORT E CRAWFORD M GERSTENBLITH G HARKER LA SMITH H TILLEY B ANDERSON J TERRIN ML TOFLER G SCHERLIS L BAKER WP COWLEY M GUERCI AD HIRSHFELD JW
Citation: E. Braunwald et al., EFFECTS OF TISSUE-PLASMINOGEN ACTIVATOR AND A COMPARISON OF EARLY INVASIVE AND CONSERVATIVE STRATEGIES IN UNSTABLE ANGINA AND NON-Q-WAVE MYOCARDIAL-INFARCTION - RESULTS OF THE TIMI IIIB TRIAL, Circulation, 89(4), 1994, pp. 1545-1556
ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH UNSTABLE ANGINA
Authors: DIAZ MN BECKER RC
Citation: Mn. Diaz et Rc. Becker, ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH UNSTABLE ANGINA, Cardiology, 84(6), 1994, pp. 380-384
SEX-RELATED OUTCOME DIFFERENCES AFTER ACUTE MYOCARDIAL-INFARCTION - RESPONSE
Authors: BECKER RC TERRIN ML KNATTERUD G
Citation: Rc. Becker et al., SEX-RELATED OUTCOME DIFFERENCES AFTER ACUTE MYOCARDIAL-INFARCTION - RESPONSE, Annals of internal medicine, 121(10), 1994, pp. 815-816
Risultati: 1-25 | 26-50 | 51-75 | 76-85